IS2421B - Nýir etónógestrel esterar - Google Patents

Nýir etónógestrel esterar

Info

Publication number
IS2421B
IS2421B IS7528A IS7528A IS2421B IS 2421 B IS2421 B IS 2421B IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A IS 2421 B IS2421 B IS 2421B
Authority
IS
Iceland
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
etonogestrel
Prior art date
Application number
IS7528A
Other languages
English (en)
Other versions
IS7528A (is
Inventor
De Nijs Henrik
Adrianus Antonius Van Der Voort Hendrikus
Leysen Dirk
Jan Grootenhuis Arij
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of IS7528A publication Critical patent/IS7528A/is
Publication of IS2421B publication Critical patent/IS2421B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7528A 2002-05-30 2004-11-15 Nýir etónógestrel esterar IS2421B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30
PCT/EP2003/050187 WO2003102012A2 (en) 2002-05-30 2003-05-22 New etonogestrel esters

Publications (2)

Publication Number Publication Date
IS7528A IS7528A (is) 2004-11-15
IS2421B true IS2421B (is) 2008-10-15

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7528A IS2421B (is) 2002-05-30 2004-11-15 Nýir etónógestrel esterar

Country Status (31)

Country Link
US (1) US7323454B2 (is)
EP (1) EP1513861B1 (is)
JP (1) JP4716726B2 (is)
KR (1) KR20050009723A (is)
CN (2) CN1314701C (is)
AR (1) AR040130A1 (is)
AT (1) ATE349458T1 (is)
AU (1) AU2003238081B2 (is)
BR (1) BR0311254A (is)
CA (1) CA2487722C (is)
CO (1) CO5631449A2 (is)
DE (1) DE60310714T2 (is)
DK (1) DK1513861T3 (is)
ES (1) ES2277085T3 (is)
HK (1) HK1072609A1 (is)
HR (1) HRP20041101A2 (is)
IL (1) IL165087A0 (is)
IS (1) IS2421B (is)
MX (1) MXPA04011797A (is)
NO (1) NO20044898L (is)
NZ (1) NZ536619A (is)
PE (1) PE20040068A1 (is)
PL (1) PL373855A1 (is)
PT (1) PT1513861E (is)
RS (1) RS97604A (is)
RU (1) RU2325910C2 (is)
SI (1) SI1513861T1 (is)
TW (1) TW200403065A (is)
UA (1) UA80126C2 (is)
WO (1) WO2003102012A2 (is)
ZA (1) ZA200410410B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
KR101406415B1 (ko) 2005-07-15 2014-06-19 미셀 테크놀로지즈, 인코포레이티드 제어된 형태의 약물 분말을 함유하는 중합체 코팅
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
PL2019657T3 (pl) 2006-04-26 2015-10-30 Micell Technologies Inc Powłoki zawierające wiele leków
JP5603598B2 (ja) 2007-01-08 2014-10-08 ミセル テクノロジーズ、インコーポレイテッド 生物分解層を有するステント
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
AU2009251504B2 (en) 2008-04-17 2013-09-05 Micell Technologies, Inc. Stents having bioabsorbable layers
CA2730995C (en) 2008-07-17 2016-11-22 Micell Technologies, Inc. Drug delivery medical device
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
CA2756386C (en) 2009-03-23 2019-01-15 Micell Technologies, Inc. Drug delivery medical device
JP2012522589A (ja) 2009-04-01 2012-09-27 ミシェル テクノロジーズ,インコーポレイテッド 被覆ステント
CA2759015C (en) 2009-04-17 2017-06-20 James B. Mcclain Stents having controlled elution
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
CA2797110C (en) 2010-04-22 2020-07-21 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
JP6330024B2 (ja) 2013-03-12 2018-05-23 マイセル・テクノロジーズ,インコーポレイテッド 生体吸収性バイオメディカルインプラント
WO2014186532A1 (en) 2013-05-15 2014-11-20 Micell Technologies, Inc. Bioabsorbable biomedical implants
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
AU692504B2 (en) 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
AU6614096A (en) * 1995-07-17 1997-02-18 Schering Aktiengesellschaft Agent, for transdermal application, containing esters of 3-ketodesogestrel
CZ293319B6 (cs) 1998-06-19 2004-04-14 Akzo Nobel N. V. Derivát testosteronu a farmaceutický prostředek s jeho obsahem
AU4513099A (en) 1998-06-19 2000-01-10 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
AR040130A1 (es) 2005-03-16
SI1513861T1 (sl) 2007-06-30
MXPA04011797A (es) 2005-03-31
TW200403065A (en) 2004-03-01
CO5631449A2 (es) 2006-04-28
IL165087A0 (en) 2005-12-18
US20050222113A1 (en) 2005-10-06
IS7528A (is) 2004-11-15
JP4716726B2 (ja) 2011-07-06
US7323454B2 (en) 2008-01-29
WO2003102012A3 (en) 2004-04-22
UA80126C2 (en) 2007-08-27
CN1314701C (zh) 2007-05-09
PE20040068A1 (es) 2004-02-18
RS97604A (en) 2006-10-27
DK1513861T3 (da) 2007-04-10
EP1513861A2 (en) 2005-03-16
ZA200410410B (en) 2006-02-22
PT1513861E (pt) 2007-03-30
CN1692122A (zh) 2005-11-02
HRP20041101A2 (en) 2004-12-31
WO2003102012A9 (en) 2005-01-13
ATE349458T1 (de) 2007-01-15
RU2325910C2 (ru) 2008-06-10
BR0311254A (pt) 2005-03-15
PL373855A1 (en) 2005-09-19
AU2003238081A1 (en) 2003-12-19
NZ536619A (en) 2007-09-28
CA2487722A1 (en) 2003-12-11
WO2003102012A2 (en) 2003-12-11
EP1513861B1 (en) 2006-12-27
CN101100480A (zh) 2008-01-09
NO20044898L (no) 2005-02-25
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
HK1072609A1 (en) 2005-09-02
JP2005532350A (ja) 2005-10-27
DE60310714D1 (de) 2007-02-08
ES2277085T3 (es) 2007-07-01
KR20050009723A (ko) 2005-01-25
AU2003238081B2 (en) 2008-09-18
RU2004138807A (ru) 2005-05-27

Similar Documents

Publication Publication Date Title
HK1072609A1 (en) New etonogestrel esters
IS7743A (is) Samskiptavír
IS8714A (is) Kínasólínafleiður
DE60330526D1 (de) Tonerteilchenherstellungsvervahren
DE60231753D1 (de) Betonsteintexturiermaschine
DE50310866D1 (de) Flanschverbindung
IS7498A (is) ökulagsriti
NO20044007L (no) Skjaerelokaliseringsverktoy
NO20023668D0 (no) Stigerörstrekkanordning
DE60228135D1 (de) Eifen
DE60336678D1 (de) Eitaktsp lmotors
NO20034147D0 (no) Trykkföleranordning
DE60323585D1 (de) Seilzugeinstellseinrichtung
IS7537A (is) Notkun á nýjum etónógestrel esterum.
DE50214840D1 (de) Ethylestern
ITMI20021327A1 (it) Nuove ossialchilpiperazine
ATE396192T1 (de) N-sulfonylaminothiazole
DE60313086D1 (de) Telewebgerät
DE60205924D1 (de) Mikrogreifer
AT5889U3 (de) Brennholzspleisser
NO20043433L (no) Fremgangsmate
DE60219966D1 (de) Virtuelles kegeln
FI5597U1 (fi) Yösähkövaraaja
FI5670U1 (fi) Luistin
DE10348105B4 (de) Umwerferschelle